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BiosensorThe identiﬁcation of antigen that induces activation of mast cells and basophils by crosslinking IgE bound
to the cell surface is crucial to avoid symptoms of allergic diseases. Surface plasmon resonance imaging
(SPRI) possesses a great potential for clinical diagnosis of allergy, in that it reveals living cell activation
following the binding of antigens to IgE, on real-time and single cell basis without artiﬁcial labeling. How-
ever, present technique of SPRI requires freshly isolated basophils of patients and cannot analyze multi-
ple samples in parallel. To overcome such problems, we developed devices for SPRI to make a broad
observation area and a multi-well SPRI sensor chip with a hydrophobic membrane. The employment
of human IgE receptor-expressing mast cell lines (RBL-48 cells) sensitized with serum, collected and
stored from less than a microliter of patient’s blood, allowed us to detect speciﬁc reactions of RBL-48 cells
in response to antigens. This technique may be a useful tool as a high throughput screening system of
type I allergy not only for freshly prepared basophils but also for sera stored in clinical practices.
 2014 The Authors. Published by Elsevier B.V. This is an open access articleunder the CCBY license (http://
creativecommons.org/licenses/by/3.0/).1. Introduction
Basophils, resident in blood, and mast cells, resident in connec-
tive and mucosal tissues, have important roles in type I allergy or
IgE-associated diseases, such as food allergy, hay fever, and atopic
dermatitis (AD). The binding of antigen (also called allergen in the
ﬁeld of allergy) to IgE bound to the high-afﬁnity IgE receptor
(FceRI) on the surface of basophils and mast cells cross-links FceRI,
resulting in the release of preformed and newly synthesized
inﬂammatory mediators, such as histamine, arachidonic acid
metabolites and cytokines, and causes allergic symptom (Fig 1)
[1–3]. Therefore, the identiﬁcation of antigens that provoke mast
cell and basophils-induced allergic reactions is crucial to avoid
anaphylactic shock and aggravations of allergic diseases. Speciﬁc
binding of antigens to the corresponding IgE may be detected by
various immunological methods, such as ELISA. However, these
tests cannot evaluate whether or not the antigen-binding IgE acti-
vates mast cells and basophils in patients. Therefore, the evaluat-
ing the potential of antigen-speciﬁc IgE to activate mast cells and
basophils from a patient is more important than the analysis of
simple IgE–antigen binding in the diagnosis of type I allergy [4–6].Surface plasmon resonance (SPR) sensors can characterize the
binding of detectants in the detection area on a SPR sensor chip
coated with gold thin ﬁlm (50 nm) in real time without any label-
ing [7,8]. They provide a useful means to study the interaction of
various biological molecules, ranging from proteins, oligonucleo-
tides, and lipids to small particles, such as phages, viral particles
as well as cells [9–15]. We previously reported that SPR sensors
could detect real-time large changes of refractive index (RI) in
response to the activation of living cells, such as mast cells, kerat-
inocytes, human basophils and B lymphocytes on a sensor chip
without any labeling. We also revealed that SPR reﬂects sequential
events of intracellular signaling rather than the binding of ligands
on cell surface, suggesting the potential of SPR as a tool for cell
analysis in basic research and diagnosis for allergy and immunol-
ogy [16–22].
Moreover, we recently developed an SPR imaging (SPRI) system
in order to visualize RI changes in individual cells induced by stim-
uli, and analyze the subcellular distribution of RI changes [23]. The
SPRI sensor could visualize the activation of human basophils
isolated from patient’s blood in response to various antigens at sin-
gle cell levels, suggesting the potential of the sensor as a tool for
diagnostics of type I allergy [24,25]. However, the diagnosis tech-
nique using SPRI sensor requires fresh basophils isolated from
patient’s blood (within 2 day after collection) and can analyze only
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reported that an RBL-48 cell line expressing the a-subunit of FceRI
and sensitized with human IgE was activated with anti-human IgE
antibody (anti-IgE) or speciﬁc antigens which induced allergic
reaction in a patient (Fig. 1) [26]. Therefore, RBL-48 cells sensitized
with serum IgE of patients may be used to detect speciﬁc and bio-
logically active IgE that induces allergic reactions in response to
antigens. In this study, we constructed an SPRI sensor with a broad
detection area to make for multiple detection spots, and analyzed
the reaction of RBL-48 cells, but not fresh human basophils, sensi-
tized with human IgE in less than a microliter of peripheral blood
in response to various antigens.Flow in Flow out2. Materials and methods
2.1. Reagents
Chemicals used were obtained from the following sources:
bovine serum albumin (BSA) from Sigma–Aldrich Japan (Tokyo,
Japan). Anti-IgE from BETYL (Montgomery, TX, USA); mite
extract-Df and cedar pollen extract-Cj from Cosmo Bio Co., Ltd.
(Tokyo, Japan). Fetal calf serum (FCS) from Biowest (Nuaillé,
France). Penicillin/streptomycin, trypsin and G418 were from Life
Technologies (Carlsbad, CA, USA).
2.2. Cells lines
The RBL-48 cell line was derived from a rat basophilic leukemia
(RBL)-2H3 cell line transfected with the human a-subunit of FceRI,
kindly supplied as a gift by Dr. Joko Kochan (Hoffmann-La Roche,
Nutley, NJ, USA) and cultured in IMDM medium supplemented
with 10% fetal calf serum (FCS), 100 U/ml penicillin, 100 lg/ml
streptomycin, and 0.5 mg/ml G418 [27]. The day before experi-
ments, RBL-48 cells were harvested using trypsin. They were then
cultured in the presence of human serum in a ratio of cells suspen-
sion (2.0  105/ml): serum of 30:1 (ex 30 ll and 1 ll). The volume
of cell suspension on a uni-compartment and multi-well SPRI sen-
sor chip were 60 ll and 3 ll respectively. Cells density at the SPR
measurement was approximately 60% conﬂuent.
2.3. Instrument for SPR imaging (SPRI)
A uni-compartment SPRI sensor with an objective lens (4) for
detection of single cell reactions was constructed as described
previously [23]. A multi-well SPRI sensor for broad detection area
was composed of a light source (640 nm LED, Ocean Optics),
achromatic lens (Sigma koki Co., Ltd., Tokyo, Japan), P-polarizer
(Sigma Koki Co., Ltd.), prism (S-LAL10, RI = 1.72), thermostat and
telecentric lens (0.6, Edmund, Barrington, NJ, USA) and CMOS
camera (Monochrome-digital CMOS camera, 1280  1024 pixel
15 fps, Japan) (Fig. 1b). The SPRI sensor chips (S-LAL10,antigen
Human IgE receptor
IgE from human serum acvaon
RBL-48 cells
An-IgE
Fig. 1. Scheme of RBL-48 cells activation. IgEs in serum bind to IgE receptors
expressed on the surface of the RBL-48 cell. The crosslinkage of IgEs by an anti-
human IgE antibody or multivalent antigen induces the activation of RBL-48 cells.20 mm  20 mm  1 mm, RI = 1.72) were coated with gold thin
ﬁlm (1 nm Cr layer and 49 nm gold layer) by means of vapor depo-
sition (Osaka Vacuum Industrial Co., Ltd., Osaka, Japan). The ﬂow
chamber was composed of a cover glass, polyvinyl chloride tubes
and a silicone rubber (20 mm  20 mm  5 mm) from which the
center was cut out as a ﬂow space (Fig. 2). Obtained images and
changes of light intensity of reﬂected light were analyzed with
Image-Pro Plus (Media Cybernetics, Inc. Rockville, MD, USA).2.4. SPRI measurement
RBL-48 cells were cultured on a uni-compartment SPRI sensor
chip or multi-well SPRI sensor chip with or without human serum
collected from peripheral blood. The sensor chip, on which living
cells were cultured, was placed on a prism with matching ﬂuid
(RI = 1.72). The ﬂow cell was placed on the sensor chip and then
washed with 1,4-piperazinediethanesulfonic acid (PIPES) buffer
at 37 C. The stimulation was performed in the ﬂow chamber by
injection with a manual syringe at 37 C. Two dimensional images
were created from the light reﬂected at the interface between the
gold ﬁlm and glass using an objective lens and a CMOS camera. Liv-
ing cells and living cell reactions were visualized by the difference
of RI between buffer solution and living cells as described previ-
ously [17–19]. Images which show the distribution of reﬂected
light intensity were taken every 10 s using the CMOS camera. SPRI
sensor chips were disposed after each assay in order to obtain reli-
able results. The change of light intensity (reﬂective index changes)
surrounded by area of interest (AOI), from which the intensities of
the area without cells was subtracted as background at each time
point, was plotted versus time (seconds) with Image-Pro.2.5. Release of b–hexosaminidase (beta hexosaminidase assay and
histamine release test)
Degranulation of RBL-48 cells was evaluated with the release of
b-hexosaminidase, a granule marker, by the hydrolysis of p-nitro-
phenyl-N-acetyl-b-D-glucosaminide to the chromatophore, p-
nitrophenol as described previously.2.6. Subjects
Levels of total and speciﬁc serum IgE against cedar pollen anti-
gen and mite antigen measured by Phadia’s total and speciﬁc IgE








Fig. 2. Scheme of SPRI for broad area. The sensor is composed of an LED (640 nm),
an achromatic lens, a P-polarizer, a S-LAL10 (RI = 1.72) glass prism, a sensor chip (S-
LAL10) coated with gold ﬁlm (50 nm), an objective lens (0.6) and a CMOS camera.
The SPRI sensor chip, on which RBL-48 cells were cultured with human serum, was
placed on the prismwith matching solution (RI = 1.72). The light was directed to the
prism surface at the incident angle 56.
Table 1
Levels of total serum IgE and antigen-speciﬁc IgE measured by Phadia’s total and speciﬁc IgE test, and reactions to sweat antigen of subjects.
Total IgE (IU/ml) aMite-IgE (UA/ml) score (0–6) aCedar-IgE (UA/ml) score (0–6) Reaction to sweat antigen
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3.1. SPR imaging sensor could detect the activation of RBL-48 cells
treated with human serum in response to anti-IgE
Multivalent antigen or anti-IgE can crosslink IgE antibody-FceRI
complex on RBL-48 cells, resulting in the activation of the cells
(Fig. 1). We ﬁrst investigated the histamine release (degranulation)
from RBL-48 cells treated with human serum overnight in response
to anti-IgE. As shown in Fig. 3a, RBL-48 cells treated with human
serum, but not those without serum, were activated in response
to anti-IgE antibody. We then observed RI changes in individual
RBL-48 cells in response to anti-IgE using an SPRI system with
4 objective lens, as described previously [23]. As shown in
Fig. 3b, reﬂected light intensity in individual RBL-48 cells cultured
with human serum increased in the presence of anti-IgE (Smovie
1), but not in the absence of anti-IgE (Smovie 2).
In order to perform multiple spot cell analysis by SPRI sensor,
we then constructed an SPRI sensor that can observe RI distribu-
tion in a broad area (20 mm  20 mm) on a SPRI sensor chip, as
described in Section 2 (Fig. 2). Using the SPRI sensor, we investi-
gated RI changes in RBL-48 cells cultured with human serum on
the SPRI sensor chip in response to anti-IgE. Fig. 4a shows images
of RI of RBL-48 cells, treated with human serum and exposed to, or
not exposed to anti-IgE at indicated time points. In the absence of
anti-IgE, RI in RBL-48 cells was not changed (Fig. 4a upper panels,
Smovie 3), but clearly increased in response to anti-IgE (Fig. 4a
lower panels, Smovie 4). The changes of RI in cell areas were plot-
ted in Fig. 4b. When RBL-48 cells treated with human serum were
stimulated with anti-IgE, RI in cells began to increase within a few
minutes, and lasted or continued to increase for more than 30 min
(Fig. 4b). These results indicate that the sensor can visualize RI
changes of RBL-48 cells cultured with human serum in response
to anti-IgE in a real time manner.(a) (
Fig. 3. Activation of RBL-48 cells treated with human serum in response to anti-IgE. (a) B
serum was induced in response to anti-human IgE antibodies (anti-IgE). (b) RI changes in
sensor constructed as described previously.3.2. Development of multi-well SPRI sensor chip
In order to perform multiple spots cell analysis for clinical diag-
nosis, we then developed a multi-well SPRI sensor chip. As shown
in Fig. 5a, nine wells for living cell culture and analysis were con-
structed with a hydrophobic membrane on the SPRI sensor chip.
The multi-well SPRI sensor chip allowed us to place 3 ll culture
medium in each well. Thus, 3 ll of RBL-48 cells suspension con-
taining 0.1 ll human serum were successfully cultured in each of
the wells (Fig. 5b). Fig. 5c shows RBL-48 cells cultured in a well
observed under a phase-contrast microscope. These results suggest
that RBL-48 cells can be cultured in each well of the multi-well
SPRI sensor chip with less than one microliter of serum of a patient.
3.3. Multiple spots analysis of RBL-48 cells treated with human serum
from patients in response to antigen
To investigate the potential of an SPRI sensor with a multi-well
sensor chip as a tool for diagnosis of type I allergy, we investigated
the reaction of RBL-48 cells cultured with sera from various
donors: donor 1 with pollen allergy (HF), donor 2 without allergic
disease, donor 3 with atopic dermatitis (AD), donor 4 with mild
asthma. Sensitivities of the donors are shown in Table 1. RBL-48
cells cultured with serum of donor 1 (pollen hypersensitivity,
(Fig 6a, bottom 3 wells) increased their RI in response to cedar pol-
len antigen, but those cultured with serum of donor 2 (Fig 6a, no
allergy, top 3 wells) and those cultured without human serum
(Fig 6a, middle 3 wells) did not change their RI (Smovie 5). Average
changes of the intensities in upper and lower lane wells were plot-
ted in the bottom panel of Fig. 6a. The intensity in the middle lane
(3 wells) was subtracted as background at each time points. RBL-48
cells cultured with serum of donor 3 with AD, but those cultured
with serum of donor 4 without AD changed their RI in response
to sweat antigen (Fig. 6b, Smovie 6) [28]. On the other hand, bothb)
Reﬂected light intensity






eta-hexosaminidase release (degranulation) in RBL-48 cells sensitized with human






0 min 30 min(a) (b)
Fig. 4. RI distribution of RBL-48 cells. (a) RI distribution changes of RBL-48 cells were observed by the SPRI sensor. The areas with high RI show RBL-48 cells. White bar shows
ca. 10 mm. (b) The time course of RI changes in the area with RBL-48 cells in the presence or absence of anti-IgE was plotted at every 10 s. Dotted circle shows a typical area of
AOI in which the sensor detects changes of reﬂected light intensity.
(a) (b) 
(c) 
Fig. 5. Development of multi-well SPRI sensor chip for multiple spots cell culture. (a) Multi-well (9 wells) SPRI sensor chip were constructed with a hydrophobic membrane.
The diameter of each well was 2 mm. (b) A cell suspension (3 ll) containing 0.1 ll human serum was dropped onto the multi-well SPRI sensor chip. The image was taken by a
digital camera. White bar shows ca. 1 mm. (c) RBL-48 cells were cultured in a well overnight with human serum observed under differential interference contrast microscopy.
White bar shows ca. 1 mm. Similar results were obtained from three independent experiments.
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of donor 4 changed their RI in response to mite antigen (Fig. 6c,
Smovie 7). The change of intensities in RBL-48 cells cultured with
serum from donor 3 or 4 in response to sweat antigen and mite
antigen were plotted in the bottom panels of Fig. 6b and 6c, respec-
tively. These results suggest that the multi-well SPRI sensor can
sufﬁciently detect speciﬁc activation of RBL-48 cells in response
to antigens by monitoring RI changes in each well.4. Discussion
The identiﬁcation of antigens that provokes mast cell and baso-
phils activation is crucial to avoid anaphylactic shock and the
aggravation of allergic and/or atopic diseases, such as food allergy,
allergic rhinitis, atopic dermatitis and asthma. The detection of
antigen speciﬁc IgE in serum implies hypersensitivity against the
antigen. Thus, a variety of immunological methods to detect anti-
gen speciﬁc IgE, have been developed and utilized in clinical prac-
tice [29]. However, there are often substantial discrepancies
between these serological tests and clinical symptoms. In vivo
tests, such as skin tests and antigen challenge tests, are more reli-
able in reﬂecting the clinical scenario. However, these tests may bephysically painful for the patient, and have the potential to evoke
anaphylactic shock when a patient is extremely sensitive to a par-
ticular antigen [30]. Moreover, the intradermal injection of an anti-
gen cannot avoid the risk of sensitization of subjects who are not
sensitized to the antigen as well as the risk of disease aggravations.
Histamine release tests which detect histamine release from baso-
phils and the detection of a surface activation marker of basophils,
such as CD203c and CD69 in vitro are safe, sensitive and widely
used as clinical examinations in the ﬁeld of allergy. However, baso-
phils of certain individuals, who show type I hypersensitivity
in vivo, neither release histamine nor express an activation marker
upon the activation of the IgE receptor in vitro (non-responders).
Moreover, fresh peripheral blood (within 1 or 2 days after collec-
tion) is required for these tests. Therefore, more sensitive and min-
imally invasive tests with high reliability and without a time
restriction are increasingly demanded for diagnosis of type I
allergy. We previously developed a basophil activation test by
means of SPRI sensor which could visualize the activation of
human basophils in response to speciﬁc antigens [24,25]. That sys-
tem required only a small amount of peripheral blood and exhib-
ited good sensitivity. However, the test also requires freshly
obtained peripheral blood (within 2 days after collection). In this
study, we developed a system based on SPRI to perform multiple
(a) (b) (c)
Fig. 6. Multi spots analysis of RBL-48 cell activations cultured on a multi-well SPRI sensor. (a) RBL-48 cells with serum of donor 1 (upper spots) or serum of donor 2 (bottom
spots) were cultured on the SPRI sensor chip and then stimulated with cedar pollen antigen for 30 min. RI in cells sensitized with serum of donor 1, but not those with serum
of donor 2, increased in response to the pollen antigen. (b) RBL-48 cells sensitized with serum of donor 3 (upper spots) or serum of donor 4 (bottom spots) were cultured on
the SPRI sensor chip and then stimulated with sweat antigen for 30 min. RI in cells sensitized with serum from donor 3, but not those with serum of donor 4, increased in
response to the sweat antigen. (c) RBL-48 cells sensitized with serum from donor 3 (upper spots) or serum from donor 4 (bottom spots) were cultured on the SPRI sensor chip
and then stimulated with mite antigen for 30 min. Both RI in cells sensitized with sera of donor 3 and those of donor 4 increased in response to the mite antigen. Intensity
changes were saturated around 30 min after stimulation and then decreased to base line within 90 min. Intensity changes due to RBL-48 cells (approximately 60% conﬂuent)
at 30 min after the stimulation with anti-IgE was approximately 3 (date not shown).
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lens (0.6) with a diaphragm, which has a long focal depth
(±1.4 mm). Therefore, the sensor developed here can detect the
reaction of single cells and/or cell clusters in a broad detection area
(>10 mm  10 mm), which is suitable for multiple spots assays.
Using this sensor, we were able to detect the activation of RBL-
48 cells sensitized with a single microliter of patient’s serum, as
a surrogate of the patient’s basophils, regardless of the storage
time and conditions, such as freezing. Since the number of cells
to detect reactions can theoretically be miniaturized down to the
single cell level, this system may be used as a good example of
applying a living cell reaction-based biosensor for a sensitive and
speciﬁc tool for various clinical diagnosis. The depth of detection
ﬁeld from the surface of gold ﬁlm on SPR sensor is less than
500 nm, which is much smaller than the cell height. Therefore,
SPR sensors detect RI changes only near the plasma membrane
sensitivity. The precise mechanism for cells to make such a large
change of RI near the plasma membrane remained unclear. How-
ever, several reports demonstrated that RI change near plasma
membrane reﬂects not only the area of cell attachment, but also
the accumulation and the rearrangement of proteins in response
to intracellular signal transductions.5. Conclusion
The technique developed in this study visualized the reactions
of multiple spotted RBL-48 cells sensitized with human serum in
response to speciﬁc antigens. Further studies to validate this tech-
nique by clinical trials and the development of SPRI sensor chipswith a larger number of wells to stimulate with different antigens
should enable us to perform a sensitive and high-throughput
screening for type I allergy with single microliter volumes of
peripheral blood.Conﬂict of Interest
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